Product image of Lactulose Mip (Lactulose) supplied by GNH India

Lactulose Mip

Active Ingredient:
Lactulose
Origin:
EU

Lactulose Mip (Lactulose)

Lactulose, the active ingredient in Lactulose Mip, is an osmotic laxative presented as an oral solution for oral administration. It is used to relieve constipation and to reduce ammonia absorption in patients with hepatic encephalopathy. The sugar‑derived disaccharide works by drawing water into the intestinal lumen, softening stools and altering gut flora to lower systemic ammonia levels.

GNH India supplies Lactulose Mip as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Manufacturer / TM Owner

Mip Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lactulose is employed in gastrointestinal and hepatic conditions where reduction of intestinal ammonia or stool softening is required.

  • Constipation: Relieves infrequent bowel movements by increasing stool water content.
  • Hepatic encephalopathy: Lowers blood ammonia levels, helping to prevent or treat episodes of neuropsychiatric dysfunction.

How It Works

  • Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, bacterial enzymes hydrolyze it to lactic acid, acetic acid and other short‑chain fatty acids, which lower colonic pH. The acidic environment promotes conversion of ammonia (NH3) to ammonium (NH4+), trapping it in the lumen, and the osmotic effect draws water into the bowel, softening stools and accelerating transit.

Side Effects

Lactulose may cause a range of adverse reactions, most of which are mild and related to its osmotic activity.

Common Side Effects

  • Flatulence: Increased intestinal gas production.
  • Diarrhoea: Loose, watery stools.
  • Abdominal cramping: Stomach discomfort or pain.
  • Nausea: Feeling of sickness.
  • Bloating: Sensation of abdominal fullness.

Serious or Rare Side Effects

  • Electrolyte imbalance: Low potassium or sodium levels.
  • Dehydration: Significant fluid loss leading to weakness.
  • Severe abdominal pain: Persistent or worsening pain.
  • Allergic reaction: Rash, itching, or swelling.
  • Hypernatremia: Elevated blood sodium in rare cases.

Precautions & Warnings

When prescribing Lactulose, clinicians should consider several safety measures to minimize risks.

  • Dose titration: Adjust the amount to achieve 2–3 soft stools per day.
  • Fluid intake: Encourage adequate hydration to prevent dehydration.
  • Renal impairment: Monitor kidney function as osmotic load may affect electrolyte balance.
  • Diabetes: Use caution as Lactulose contains minimal fermentable sugars.
  • Pediatric use: Dose must be individualized; safety data are limited.
  • Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Avoid Interactions

Lactulose can interact with other medicines, influencing their absorption or effect.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: May reduce Lactulose efficacy by neutralizing acidity.
  • Antibiotics (e.g., rifaximin): Concurrent use may alter gut flora and affect ammonia reduction.

Moderate Interactions (Monitor Closely)

  • Diuretics: Increased risk of electrolyte disturbances.
  • Insulin or oral hypoglycemics: Monitor blood glucose as Lactulose can affect carbohydrate metabolism.
  • Mineral supplements (iron, calcium): May bind to Lactulose and diminish its action.

Frequently Asked Questions

Lactulose Mip is used to treat constipation by increasing the water content of stools, and to manage hepatic encephalopathy by lowering ammonia levels in the gut, thereby helping to prevent or reduce neuropsychiatric symptoms in patients with liver disease.

Lactulose is a synthetic sugar that reaches the colon unchanged, where bacteria break it down into acidic metabolites. This lowers colonic pH, converting ammonia to non‑absorbable ammonium, and creates an osmotic gradient that draws water into the bowel, softening stools and speeding intestinal transit.

The dose of Lactulose Mip is individualized by the prescribing clinician based on the patient’s condition, response, and tolerance. The prescriber determines the appropriate amount and frequency to achieve the desired therapeutic effect.

Safety data for Lactulose Mip in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Lactulose Mip, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative that works by increasing colonic water content, whereas stimulant laxatives such as bisacodyl act by stimulating intestinal motility. Lactulose also has the unique benefit of reducing ammonia absorption, making it the preferred choice for patients with hepatic encephalopathy.

Lactulose Mip should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lactulose Mip is administered orally. It may be taken directly as a liquid or mixed with a small amount of water or juice to improve palatability, following the dosage instructions provided by the prescribing healthcare professional.

Serious risks include electrolyte imbalances such as low potassium or sodium, severe dehydration, and rare allergic reactions. Patients should be monitored for signs of these conditions, especially if they have renal impairment or are taking diuretics.

Lactulose Mip should be avoided in individuals with known hypersensitivity to lactulose or any component of the formulation, and it should be used with caution in patients with severe renal impairment, intestinal obstruction, or uncontrolled diabetes, unless directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.